{"entity":{"type":"insider","cik":"0001559583","url":"/insider/0001559583","json_url":"/insider/0001559583.json","name":"Smither John W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":54,"n_filings":38,"first":"2013-05-03","last":"2026-07-02","span_basis":"filed_date"},"name_variants":[{"name":"Smither John W","source":"filing","n_filings":38,"first_seen":"2013-05-03","last_seen":"2026-07-02"}],"transactions":[{"id":5834358,"accession":"0001493152-26-031927","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-26-031927","line_url":"/filing/0001493152-26-031927#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":2.9082,"price_display":"2.91","price_state":"stated","total_value":34898.4,"total_display":"34,898.40","shares_owned_after":91403.0,"shares_owned_after_display":"91,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider"},{"id":2929461,"accession":"0001415889-24-016109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-016109","line_url":"/filing/0001415889-24-016109#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6250.0,"shares_display":"6,250","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":13170.0,"shares_owned_after_display":"13,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-29","filed_date":"2024-06-07","scope":"insider"},{"id":7816476,"accession":"0001209191-23-049519","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049519","line_url":"/filing/0001209191-23-049519#line-1","is_derivative":false,"issuer_cik":"0001231457","issuer_name":"GENELUX Corp","issuer_ticker":"GNLX","issuer_name_source":null,"issuer_url":"/issuer/0001231457","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":20.78,"price_display":"20.78","price_state":"stated","total_value":18702.0,"total_display":"18,702.00","shares_owned_after":6920.0,"shares_owned_after_display":"6,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-13","filed_date":"2023-09-14","scope":"insider"},{"id":5074820,"accession":"0001567619-21-006086","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-006086","line_url":"/filing/0001567619-21-006086#line-3","is_derivative":false,"issuer_cik":"0001559583","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001559583","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":32.9,"price_display":"32.90","price_state":"stated","total_value":41125.0,"total_display":"41,125.00","shares_owned_after":86715.0,"shares_owned_after_display":"86,715","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-03-10","filed_date":"2021-03-11","scope":"insider"},{"id":5074812,"accession":"0001567619-21-006086","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-006086","line_url":"/filing/0001567619-21-006086#line-2","is_derivative":false,"issuer_cik":"0001559583","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001559583","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":32.9,"price_display":"32.90","price_state":"stated","total_value":16450.0,"total_display":"16,450.00","shares_owned_after":46321.0,"shares_owned_after_display":"46,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-10","filed_date":"2021-03-11","scope":"insider"},{"id":5437050,"accession":"0001567619-21-005540","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-005540","line_url":"/filing/0001567619-21-005540#line-1","is_derivative":false,"issuer_cik":"0001559583","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001559583","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":773.0,"shares_display":"773","price_per_share":34.204,"price_display":"34.20","price_state":"stated","total_value":26439.692,"total_display":"26,439.69","shares_owned_after":24425.0,"shares_owned_after_display":"24,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-03","scope":"insider"},{"id":4698860,"accession":"0001567619-21-003626","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-003626","line_url":"/filing/0001567619-21-003626#line-3","is_derivative":false,"issuer_cik":"0001559583","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001559583","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":35.64,"price_display":"35.64","price_state":"stated","total_value":71280.0,"total_display":"71,280.00","shares_owned_after":87965.0,"shares_owned_after_display":"87,965","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-12","scope":"insider"},{"id":4698855,"accession":"0001567619-21-003626","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-003626","line_url":"/filing/0001567619-21-003626#line-2","is_derivative":false,"issuer_cik":"0001559583","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001559583","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":35.64,"price_display":"35.64","price_state":"stated","total_value":26730.0,"total_display":"26,730.00","shares_owned_after":25198.0,"shares_owned_after_display":"25,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-12","scope":"insider"},{"id":5463796,"accession":"0001567619-21-002077","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-002077","line_url":"/filing/0001567619-21-002077#line-3","is_derivative":false,"issuer_cik":"0001559583","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001559583","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":131250.0,"total_display":"131,250.00","shares_owned_after":89965.0,"shares_owned_after_display":"89,965","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider"},{"id":5463794,"accession":"0001567619-21-002077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-002077","line_url":"/filing/0001567619-21-002077#line-2","is_derivative":false,"issuer_cik":"0001559583","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001559583","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":43750.0,"total_display":"43,750.00","shares_owned_after":25198.0,"shares_owned_after_display":"25,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-01","filed_date":"2021-02-03","scope":"insider"},{"id":5376734,"accession":"0001567619-21-001340","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-001340","line_url":"/filing/0001567619-21-001340#line-3","is_derivative":false,"issuer_cik":"0001559583","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001559583","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":37500.0,"total_display":"37,500.00","shares_owned_after":93715.0,"shares_owned_after_display":"93,715","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-21","scope":"insider"},{"id":5376732,"accession":"0001567619-21-001340","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-21-001340","line_url":"/filing/0001567619-21-001340#line-2","is_derivative":false,"issuer_cik":"0001559583","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001559583","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","shares_owned_after":25198.0,"shares_owned_after_display":"25,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-21","scope":"insider"},{"id":2873049,"accession":"0001567619-20-021190","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-021190","line_url":"/filing/0001567619-20-021190#line-3","is_derivative":false,"issuer_cik":"0001559583","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001559583","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":112500.0,"total_display":"112,500.00","shares_owned_after":94965.0,"shares_owned_after_display":"94,965","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider"},{"id":2873045,"accession":"0001567619-20-021190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-021190","line_url":"/filing/0001567619-20-021190#line-2","is_derivative":false,"issuer_cik":"0001559583","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001559583","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":45000.0,"total_display":"45,000.00","shares_owned_after":25198.0,"shares_owned_after_display":"25,198","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider"},{"id":2080287,"accession":"0001567619-20-017381","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-20-017381","line_url":"/filing/0001567619-20-017381#line-3","is_derivative":false,"issuer_cik":"0001559583","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001559583","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":37500.0,"total_display":"37,500.00","shares_owned_after":98715.0,"shares_owned_after_display":"98,715","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-29","filed_date":"2020-10-01","scope":"insider"},{"id":2080286,"accession":"0001567619-20-017381","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-20-017381","line_url":"/filing/0001567619-20-017381#line-2","is_derivative":false,"issuer_cik":"0001559583","issuer_name":"Arcutis Biotherapeutics, Inc.","issuer_ticker":"ARQT","issuer_name_source":null,"issuer_url":"/issuer/0001559583","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","shares_owned_after":23875.0,"shares_owned_after_display":"23,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-29","filed_date":"2020-10-01","scope":"insider"},{"id":8689936,"accession":"0001104659-15-067094","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001104659-15-067094","line_url":"/filing/0001104659-15-067094#line-8","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13763.0,"shares_display":"13,763","price_per_share":74.9,"price_display":"74.90","price_state":"stated","total_value":1030848.7,"total_display":"1,030,848.70","shares_owned_after":3368.0,"shares_owned_after_display":"3,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-24","filed_date":"2015-09-24","scope":"insider"},{"id":8689934,"accession":"0001104659-15-067094","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-15-067094","line_url":"/filing/0001104659-15-067094#line-7","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13154.0,"shares_display":"13,154","price_per_share":74.9,"price_display":"74.90","price_state":"stated","total_value":985234.6,"total_display":"985,234.60","shares_owned_after":3368.0,"shares_owned_after_display":"3,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-24","filed_date":"2015-09-24","scope":"insider"},{"id":8689927,"accession":"0001104659-15-067094","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-15-067094","line_url":"/filing/0001104659-15-067094#line-4","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13646.0,"shares_display":"13,646","price_per_share":74.9,"price_display":"74.90","price_state":"stated","total_value":1022085.4,"total_display":"1,022,085.40","shares_owned_after":3368.0,"shares_owned_after_display":"3,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-23","filed_date":"2015-09-24","scope":"insider"},{"id":8689923,"accession":"0001104659-15-067094","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-15-067094","line_url":"/filing/0001104659-15-067094#line-3","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13272.0,"shares_display":"13,272","price_per_share":74.9,"price_display":"74.90","price_state":"stated","total_value":994072.8,"total_display":"994,072.80","shares_owned_after":3368.0,"shares_owned_after_display":"3,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-23","filed_date":"2015-09-24","scope":"insider"},{"id":8241680,"accession":"0001104659-15-066590","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-15-066590","line_url":"/filing/0001104659-15-066590#line-7","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3476.0,"shares_display":"3,476","price_per_share":74.9,"price_display":"74.90","price_state":"stated","total_value":260352.4,"total_display":"260,352.40","shares_owned_after":3368.0,"shares_owned_after_display":"3,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-22","filed_date":"2015-09-23","scope":"insider"},{"id":8241677,"accession":"0001104659-15-066590","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-15-066590","line_url":"/filing/0001104659-15-066590#line-6","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2115.0,"shares_display":"2,115","price_per_share":74.9,"price_display":"74.90","price_state":"stated","total_value":158413.5,"total_display":"158,413.50","shares_owned_after":3368.0,"shares_owned_after_display":"3,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-22","filed_date":"2015-09-23","scope":"insider"},{"id":8241666,"accession":"0001104659-15-066590","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-15-066590","line_url":"/filing/0001104659-15-066590#line-3","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1054.0,"shares_display":"1,054","price_per_share":74.95,"price_display":"74.95","price_state":"stated","total_value":78997.3,"total_display":"78,997.30","shares_owned_after":3368.0,"shares_owned_after_display":"3,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-18","filed_date":"2015-09-23","scope":"insider"},{"id":9242192,"accession":"0001179110-15-010551","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-010551","line_url":"/filing/0001179110-15-010551#line-1","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":75.5,"price_display":"75.50","price_state":"stated","total_value":347300.0,"total_display":"347,300.00","shares_owned_after":7616.0,"shares_owned_after_display":"7,616","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-25","filed_date":"2015-06-30","scope":"insider"},{"id":8772535,"accession":"0001179110-15-010311","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-010311","line_url":"/filing/0001179110-15-010311#line-1","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":75.5,"price_display":"75.50","price_state":"stated","total_value":347300.0,"total_display":"347,300.00","shares_owned_after":10984.0,"shares_owned_after_display":"10,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-25","filed_date":"2015-06-25","scope":"insider"},{"id":9223316,"accession":"0001104659-15-066589","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-066589","line_url":"/filing/0001104659-15-066589#line-1","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2041.0,"shares_display":"2,041","price_per_share":45.49,"price_display":"45.49","price_state":"stated","total_value":92845.09,"total_display":"92,845.09","shares_owned_after":3368.0,"shares_owned_after_display":"3,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-30","filed_date":"2015-09-23","scope":"insider"},{"id":8895679,"accession":"0001179110-15-006893","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-006893","line_url":"/filing/0001179110-15-006893#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2041.0,"shares_display":"2,041","price_per_share":45.49,"price_display":"45.49","price_state":"stated","total_value":92845.09,"total_display":"92,845.09","shares_owned_after":15584.0,"shares_owned_after_display":"15,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-30","filed_date":"2015-04-30","scope":"insider"},{"id":8895520,"accession":"0001179110-15-004304","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-004304","line_url":"/filing/0001179110-15-004304#line-3","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":46.99,"price_display":"46.99","price_state":"stated","total_value":93980.0,"total_display":"93,980.00","shares_owned_after":14416.0,"shares_owned_after_display":"14,416","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-05","scope":"insider"},{"id":8895518,"accession":"0001179110-15-004304","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-004304","line_url":"/filing/0001179110-15-004304#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":60000.0,"total_display":"60,000.00","shares_owned_after":12216.0,"shares_owned_after_display":"12,216","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-05","scope":"insider"},{"id":8895516,"accession":"0001179110-15-004304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-004304","line_url":"/filing/0001179110-15-004304#line-1","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":48.0,"price_display":"48.00","price_state":"stated","total_value":48000.0,"total_display":"48,000.00","shares_owned_after":13416.0,"shares_owned_after_display":"13,416","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-05","filed_date":"2015-03-05","scope":"insider"},{"id":8862524,"accession":"0001179110-15-002987","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-15-002987","line_url":"/filing/0001179110-15-002987#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":42000.0,"total_display":"42,000.00","shares_owned_after":16416.0,"shares_owned_after_display":"16,416","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-18","filed_date":"2015-02-19","scope":"insider"},{"id":8862522,"accession":"0001179110-15-002987","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-002987","line_url":"/filing/0001179110-15-002987#line-1","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":40000.0,"total_display":"40,000.00","shares_owned_after":17416.0,"shares_owned_after_display":"17,416","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-02-17","filed_date":"2015-02-19","scope":"insider"},{"id":8772327,"accession":"0001179110-15-001525","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-15-001525","line_url":"/filing/0001179110-15-001525#line-1","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":38.0,"price_display":"38.00","price_state":"stated","total_value":38000.0,"total_display":"38,000.00","shares_owned_after":18416.0,"shares_owned_after_display":"18,416","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-29","filed_date":"2015-02-02","scope":"insider"},{"id":8478028,"accession":"0001179110-15-001278","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-15-001278","line_url":"/filing/0001179110-15-001278#line-4","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":35.47,"price_display":"35.47","price_state":"stated","total_value":70940.0,"total_display":"70,940.00","shares_owned_after":20416.0,"shares_owned_after_display":"20,416","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-23","filed_date":"2015-01-27","scope":"insider"},{"id":8478024,"accession":"0001179110-15-001278","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-15-001278","line_url":"/filing/0001179110-15-001278#line-3","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":36.0,"price_display":"36.00","price_state":"stated","total_value":36000.0,"total_display":"36,000.00","shares_owned_after":19416.0,"shares_owned_after_display":"19,416","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-01-23","filed_date":"2015-01-27","scope":"insider"},{"id":6671473,"accession":"0001179110-14-018652","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-018652","line_url":"/filing/0001179110-14-018652#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":35.49,"price_display":"35.49","price_state":"stated","total_value":13308.75,"total_display":"13,308.75","shares_owned_after":16200.0,"shares_owned_after_display":"16,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-22","filed_date":"2014-12-22","scope":"insider"},{"id":6867599,"accession":"0001179110-14-016849","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-016849","line_url":"/filing/0001179110-14-016849#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":34.83,"price_display":"34.83","price_state":"stated","total_value":13061.25,"total_display":"13,061.25","shares_owned_after":16200.0,"shares_owned_after_display":"16,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-20","filed_date":"2014-11-20","scope":"insider"},{"id":6455504,"accession":"0001179110-14-015601","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-015601","line_url":"/filing/0001179110-14-015601#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":32.53,"price_display":"32.53","price_state":"stated","total_value":12198.75,"total_display":"12,198.75","shares_owned_after":16200.0,"shares_owned_after_display":"16,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-20","filed_date":"2014-10-20","scope":"insider"},{"id":7030336,"accession":"0001179110-14-014384","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-014384","line_url":"/filing/0001179110-14-014384#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":35.61,"price_display":"35.61","price_state":"stated","total_value":13353.75,"total_display":"13,353.75","shares_owned_after":16200.0,"shares_owned_after_display":"16,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-22","filed_date":"2014-09-22","scope":"insider"},{"id":6548282,"accession":"0001179110-14-013081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-013081","line_url":"/filing/0001179110-14-013081#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":35.04,"price_display":"35.04","price_state":"stated","total_value":13140.0,"total_display":"13,140.00","shares_owned_after":16200.0,"shares_owned_after_display":"16,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-20","filed_date":"2014-08-20","scope":"insider"},{"id":6514565,"accession":"0001179110-14-011887","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-011887","line_url":"/filing/0001179110-14-011887#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":33.4,"price_display":"33.40","price_state":"stated","total_value":12525.0,"total_display":"12,525.00","shares_owned_after":16200.0,"shares_owned_after_display":"16,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-21","filed_date":"2014-07-21","scope":"insider"},{"id":6252452,"accession":"0001179110-14-011439","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-011439","line_url":"/filing/0001179110-14-011439#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":90000.0,"total_display":"90,000.00","shares_owned_after":16200.0,"shares_owned_after_display":"16,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-02","filed_date":"2014-07-03","scope":"insider"},{"id":7063328,"accession":"0001179110-14-010848","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-010848","line_url":"/filing/0001179110-14-010848#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":38.06,"price_display":"38.06","price_state":"stated","total_value":14272.5,"total_display":"14,272.50","shares_owned_after":16200.0,"shares_owned_after_display":"16,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-20","filed_date":"2014-06-24","scope":"insider"},{"id":6720838,"accession":"0001179110-14-008838","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-008838","line_url":"/filing/0001179110-14-008838#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":32.2006,"price_display":"32.20","price_state":"stated","total_value":12075.225,"total_display":"12,075.22","shares_owned_after":13200.0,"shares_owned_after_display":"13,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-20","filed_date":"2014-05-21","scope":"insider"},{"id":6379590,"accession":"0001179110-14-007020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-007020","line_url":"/filing/0001179110-14-007020#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":36.12,"price_display":"36.12","price_state":"stated","total_value":13545.0,"total_display":"13,545.00","shares_owned_after":13200.0,"shares_owned_after_display":"13,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-21","filed_date":"2014-04-21","scope":"insider"},{"id":6174801,"accession":"0001179110-14-005632","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-005632","line_url":"/filing/0001179110-14-005632#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1125.0,"shares_display":"1,125","price_per_share":43.7807,"price_display":"43.78","price_state":"stated","total_value":49253.2875,"total_display":"49,253.29","shares_owned_after":10200.0,"shares_owned_after_display":"10,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-20","filed_date":"2014-03-20","scope":"insider"},{"id":7029991,"accession":"0001179110-14-003342","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-003342","line_url":"/filing/0001179110-14-003342#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2250.0,"shares_display":"2,250","price_per_share":49.745,"price_display":"49.74","price_state":"stated","total_value":111926.25,"total_display":"111,926.25","shares_owned_after":10200.0,"shares_owned_after_display":"10,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-20","filed_date":"2014-02-21","scope":"insider"},{"id":6251961,"accession":"0001179110-14-002930","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-002930","line_url":"/filing/0001179110-14-002930#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1125.0,"shares_display":"1,125","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":56250.0,"total_display":"56,250.00","shares_owned_after":10200.0,"shares_owned_after_display":"10,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-14","filed_date":"2014-02-18","scope":"insider"},{"id":6903181,"accession":"0001179110-14-001229","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-001229","line_url":"/filing/0001179110-14-001229#line-2","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1125.0,"shares_display":"1,125","price_per_share":42.5387,"price_display":"42.54","price_state":"stated","total_value":47856.0375,"total_display":"47,856.04","shares_owned_after":10200.0,"shares_owned_after_display":"10,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-21","filed_date":"2014-01-21","scope":"insider"},{"id":5018501,"accession":"0001179110-13-014064","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-13-014064","line_url":"/filing/0001179110-13-014064#line-4","is_derivative":false,"issuer_cik":"0001436304","issuer_name":"KYTHERA BIOPHARMACEUTICALS INC","issuer_ticker":"KYTH","issuer_name_source":null,"issuer_url":"/issuer/0001436304","owner_cik":"0001559583","owner_name":"Smither John W","owner_url":"/insider/0001559583","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":30.0332,"price_display":"30.03","price_state":"stated","total_value":900996.0,"total_display":"900,996.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-10","filed_date":"2013-09-10","scope":"insider"}],"next_cursor":"2013-09-10|5018501","ledger_fault":false,"count":{"value":54,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":53,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":54},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001231457","name":"GENELUX Corp","url":"/issuer/0001231457","role":"Director","n_filings":3,"first_seen":"2023-09-14","last_seen":"2026-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001787306","name":"Arcutis Biotherapeutics, Inc.","url":"/issuer/0001787306","role":"Officer (Chief Financial Officer)","n_filings":7,"first_seen":"2020-10-01","last_seen":"2021-03-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001436304","name":"KYTHERA BIOPHARMACEUTICALS INC","url":"/issuer/0001436304","role":"Officer (Chief Financial Officer)","n_filings":28,"first_seen":"2013-05-03","last_seen":"2015-09-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001559583","retrieved_at":"2026-08-21T23:54:48+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}